Stay updated on Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.

Latest updates to the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page
- CheckyesterdayChange DetectedA banner was added announcing NIH website terminology updates, and the displayed site revision changed from v3.7.1 to v3.7.2. The study page itself continues to show a 403 Forbidden error.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content and preventing access to the study details. This indicates the page is not currently accessible and blocks retrieval of study information.SummaryDifference19%

- Check36 days agoChange DetectedA new revision tag v3.7.0 has been added and the older v3.6.6 tag removed, reflecting an updated versioning label on the page.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating an updated version of the page.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor administrative update to the page documentation.SummaryDifference0.0%

Stay in the know with updates to Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.